New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Immunotherapy for HPV+ head and neck cancer: Awakening the force within

Immunotherapy for HPV+ head and neck cancer: Awakening the force within

by Emory UniversityCredit: Pixabay/CC0 Public DomainA new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the
Oncology April 16,2024
Immunotherapy for HPV+ head and neck cancer: Awakening the force within

Immunotherapy for HPV+ head and neck cancer: Awakening the force within

by Emory UniversityCredit: Pixabay/CC0 Public DomainA new study from scientists at Emory Vaccine Center and Winship Cancer Institute of Emory University reports that the immune cells that are the
Oncology April 16,2024
Is it brain infection or cancer? A new rapid test could hold the answer

Is it brain infection or cancer? A new rapid test could hold the answer

by Thomas Jefferson UniversityGram stain of meningococci from a culture showing Gram negative (pink) bacteria, often in pairs. Credit: public domainWhen patients present with neurologic symptoms
Immunology & Rheumatology April 16,2024
Is it brain infection or cancer? A new rapid test could hold the answer

Is it brain infection or cancer? A new rapid test could hold the answer

by Thomas Jefferson UniversityGram stain of meningococci from a culture showing Gram negative (pink) bacteria, often in pairs. Credit: public domainWhen patients present with neurologic symptoms
Immunology & Rheumatology April 16,2024
Alzheimer's disease study links brain health and physical activity

Alzheimer's disease study links brain health and physical activity

by IOS PressCredit: IOS PressPeople at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have health
Neurology April 16,2024
Alzheimer's disease study links brain health and physical activity

Alzheimer's disease study links brain health and physical activity

by IOS PressCredit: IOS PressPeople at risk for Alzheimer's disease who do more moderate-intensity physical activity, but not light-intensity physical activity, are more likely to have health
Neurology April 16,2024
A new breakthrough in Alzheimer's disease research: Visualizing reactive astrocyte-neuron interaction

A new breakthrough in Alzheimer's disease research: Visualizing reactive astrocyte-neuron interaction

by Institute for Basic ScienceFig. 1. Augmentation of acetate uptake, mediated by MCT1, facilitates Aβ-induced GABA release in reactive astrocyte. A. Blockade effect of MCT1 inhibitor on 14C-acet
Neurology April 16,2024
A new breakthrough in Alzheimer's disease research: Visualizing reactive astrocyte-neuron interaction

A new breakthrough in Alzheimer's disease research: Visualizing reactive astrocyte-neuron interaction

by Institute for Basic ScienceFig. 1. Augmentation of acetate uptake, mediated by MCT1, facilitates Aβ-induced GABA release in reactive astrocyte. A. Blockade effect of MCT1 inhibitor on 14C-acet
Neurology April 16,2024
What allegations of Alzheimer's research fraud mean for patients

What allegations of Alzheimer's research fraud mean for patients

by John Mamo,The ConversationCredit: AI-generated imageAlzheimer's disease is themost prevalentform of dementia and, with a rapidly aging global population, it is fueling unprece
Neurology April 16,2024
What allegations of Alzheimer's research fraud mean for patients

What allegations of Alzheimer's research fraud mean for patients

by John Mamo,The ConversationCredit: AI-generated imageAlzheimer's disease is themost prevalentform of dementia and, with a rapidly aging global population, it is fueling unprece
Neurology April 16,2024
How a rare dementia transforms patients into artists

How a rare dementia transforms patients into artists

by Suzanne Leigh,University of California, San FranciscoArtwork from a patient with semantic variant primary progressive aphasia. Credit: University of California, San FranciscoFor decades, doct
Neurology April 16,2024
How a rare dementia transforms patients into artists

How a rare dementia transforms patients into artists

by Suzanne Leigh,University of California, San FranciscoArtwork from a patient with semantic variant primary progressive aphasia. Credit: University of California, San FranciscoFor decades, doct
Neurology April 16,2024
New mechanism by which Alzheimer's disease spreads through the brain discovered

New mechanism by which Alzheimer's disease spreads through the brain discovered

by Linköping UniversityResearchers at Linköping University study how Alzheimer's disease spreads in the brain. Credit: Thor Balkhed/Linköping UniversityThe waste-management system of the cell
Neurology April 16,2024
New mechanism by which Alzheimer's disease spreads through the brain discovered

New mechanism by which Alzheimer's disease spreads through the brain discovered

by Linköping UniversityResearchers at Linköping University study how Alzheimer's disease spreads in the brain. Credit: Thor Balkhed/Linköping UniversityThe waste-management system of the cell
Neurology April 16,2024
Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

by Universitaet TübingenAmyloid proteins (plaques, blue) in the cerebral cortex of a mouse model of Alzheimer’s disease, surrounded by cortical immune cells (microglia, green). Activated microgli
Neurology April 16,2024
Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

Alzheimer's research—intracellular calcium store malfunction leads to brain hyperactivity

by Universitaet TübingenAmyloid proteins (plaques, blue) in the cerebral cortex of a mouse model of Alzheimer’s disease, surrounded by cortical immune cells (microglia, green). Activated microgli
Neurology April 16,2024
Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not
Neurology April 16,2024
Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not
Neurology April 16,2024
Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show
Neurology April 16,2024
Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show
Neurology April 16,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com